Viskase Holdings, Inc.

VISK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Jun 2025 Mar 2025 Jun 2024 Mar 2024 Sep 2023 Jun 2023
Revenue $90.1M $86.5M $97.3M $94.2M $26.0K $0 $0 $0
Cost of Revenue $79.0M $77.5M $85.6M $79.8M — — — —
Gross Profit $11.1M $9.0M $11.6M $14.4M — — — —
Gross Margin 12.3% 10.4% 12.0% 15.3% — — — —
Operating Expenses
Research & Development $649.0K $558.0K $668.0K $662.0K — — — —
SG&A Expense $12.1M $12.4M $12.9M $11.7M — — — —
Operating Income $-2.0M $-4.3M $-2.6M $-14.4M $-325.0K $-326.0K $-225.0K $-318.0K
Operating Margin -2.2% -5.0% -2.7% -15.3% -1,250.0% — — —
Interest Expense — — — — — — — —
Pretax Income $-4.8M $-6.0M $-5.9M $-15.0M $280.0K $321.0K $397.0K $235.0K
Income Tax Expense $305.0K $748.0K $14.4M $-1.4M $4.0K $1.0K $76.0K $52.0K
Net Income $-5.1M $-6.7M $-20.2M $-13.6M $276.0K $320.0K $321.0K $183.0K
Net Margin -5.6% -7.7% -20.8% -14.4% 1,061.5% — — —
EPS (Basic) $-0.35 $-0.84 $-3.74 $-2.65 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $-0.35 $-0.84 $-3.74 $-2.65 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 14.3M 7.9M 5.4M 5.1M 74.2M 74.2M 74.2M 74.2M
Shares Outstanding (Diluted) 14.3M 7.9M 5.4M 5.1M 74.2M 74.2M 74.2M 74.2M
Dividends Per Share — $0.00 — — — — — —
← Newer Page 1 of 8 Older →